| Changes in metabolic phenotypes of Plasmodium falciparum in vitro cultures during gametocyte development SD Lamour, U Straschil, J Saric, MJ Delves Malaria journal 13, 1-10, 2014 | 47 | 2014 |
| Metabolic Characterization of Leishmania major Infection in Activated and Nonactivated Macrophages. SD Lamour, BS Choi, HC Keun, I Müller, J Saric Journal of proteome research 11 (8), 4211-4222, 2012 | 41 | 2012 |
| Efficacy of an inhaled IL-13 antibody fragment in a model of chronic asthma D Lightwood, M Tservistas, M Zehentleitner, K Sarkar, A Turner, ... American journal of respiratory and critical care medicine 198 (5), 610-619, 2018 | 37 | 2018 |
| The discovery, engineering and characterisation of a highly potent anti-human IL-13 fab fragment designed for administration by inhalation D Lightwood, V O'Dowd, B Carrington, V Veverka, MD Carr, M Tservistas, ... Journal of molecular biology 425 (3), 577-593, 2013 | 37 | 2013 |
| Discovery of infection associated metabolic markers in human African trypanosomiasis SD Lamour, M Gomez-Romero, PA Vorkas, VP Alibu, J Saric, E Holmes, ... PLoS neglected tropical diseases 9 (10), e0004200, 2015 | 35 | 2015 |
| Metabolic, Immune, and Gut Microbial Signals Mount a Systems Response to Leishmania major Infection SD Lamour, KA Veselkov, JM Posma, E Giraud, ME Rogers, S Croft, ... Journal of proteome research 14 (1), 318-329, 2015 | 23 | 2015 |
| The PEG component of certolizumab pegol inhibits degranulation by stimulated mast cells S Lamour, M Bracher, A Nesbitt Arthritis Rheum 15, 16-21, 2009 | 13 | 2009 |
| In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes LM Berry, R Adams, M Airey, MG Bracher, T Bourne, B Carrington, ... International immunopharmacology 9 (2), 201-206, 2009 | 13 | 2009 |
| Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense Infection SD Lamour, VP Alibu, E Holmes, JM Sternberg The journal of infectious diseases 216 (10), 1273-1280, 2017 | 10 | 2017 |
| Novel inhaled delivery of anti-IL-13 MAb (FAb fragment): Preclinical efficacy in allergic asthma N Gozzard, D Lightwood, M Tservistas, M Zehentleitner, K Sarkar, ... European Respiratory Journal 50 (suppl 61), 2017 | 4 | 2017 |
| PEG component of certolizumab pegol inhibits stimulated mast cell degranulation: P‐0072. S Lamour, M Bracher, A Nesbitt Inflammatory Bowel Diseases 15, S28, 2009 | 1 | 2009 |
| PEG Component of Certolizumab Pegol Inhibits Stimulated Mast Cell Degranulation: 1198 A Nesbitt, S Lamour, M Bracher Official journal of the American College of Gastroenterology| ACG 104, S444, 2009 | 1 | 2009 |
| 1H NMR-based Metabolic Profiling in Infectious Disease Research J Saric, SD Lamour, JV Li | | 2018 |
| Investigation of host metabolic interactions in trypanosomatid infections SD Lamour Imperial College London, 2015 | | 2015 |
| Corrigendum to" The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation"[J. Mol. Biol. 425 … D Lightwood, V O'Dowd, B Carrington, V Veverka, MD Carr, M Tservistas, ... Journal of molecular biology 425 (11), 2082, 2013 | | 2013 |
| Investigating immune-metabolic correlation structures in experimental Leishmania major infection in vivo and in vitro [poster] SD Lamour, K Seifert, SL Croft, K Veselkov, B Choi, I Müller, E Holmes, ... GRC Tropical Infectious Diseases, 2013 | | 2013 |
| Systemic Immune-metabolic Characterisation in the Dichotomous Leishmania major-mouse Models [poster] S Lamour, K Seifert, S Croft, J Saric BSP Spring Meeting 2012, 2012 | | 2012 |
| Effect of the PEG Component of Certolizumab Pegol on Calcium Flux in Cellular Systems: 1155 A Nesbitt, S Lamour, G Fossati Official journal of the American College of Gastroenterology| ACG 105, S419, 2010 | | 2010 |
Elaine HolmesMurdoch University & Imperial College LondonBestätigte E-Mail-Adresse bei imperial.ac.uk
